Cardinal Health (NYSE: CAH) legal chief sells 29K shares

Rhea-AI Filing Summary

CARDINAL HEALTH INC (CAH) reports that Jessica L. Mayer, Chief Legal/Compliance Officer, sold an aggregate of 29,436 Common Shares on August 18, 2026. The sales occurred in four open market or private transaction tranches at weighted average prices ranging from $234.07 to $237.67 per share.

Insider Trade Summary

Net Seller: 29,436 shares

Net Sell 4 txns

Insider Mayer Jessica L

Role Chief Legal/Compliance Officer

Sold 29,436 shs ($6.95M)

Type	Security	Shares	Price	Value
Sale	Common Shares F1	3,900	$234.64	$915K
Sale	Common Shares F2	10,246	$235.51	$2.41M
Sale	Common Shares F3	4,426	$236.38	$1.05M
Sale	Common Shares F4	10,864	$237.31	$2.58M

Holdings After Transaction: Common Shares — 33,076 shares (Direct)

Footnotes (4)

1. F1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.07 to $235.05, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 2, 3, and 4 to this Form 4.
2. F2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.08 to $236.07, inclusive.
3. F3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.09 to $237.08, inclusive.
4. F4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.10 to $237.67, inclusive.

Key Figures

Total shares sold: 29,436 shares First tranche: 3,900 shares at $234.64 Second tranche: 10,246 shares at $235.51 +2 more

5 metrics

Total shares sold 29,436 shares Aggregate net shares sold by Jessica L. Mayer on 2026-08-18

First tranche 3,900 shares at $234.64 Non-derivative Common Shares sale on 2026-08-18 (weighted average price, range $234.07–$235.05)

Second tranche 10,246 shares at $235.51 Non-derivative Common Shares sale on 2026-08-18 (weighted average price, range $235.08–$236.07)

Third tranche 4,426 shares at $236.38 Non-derivative Common Shares sale on 2026-08-18 (weighted average price, range $236.09–$237.08)

Fourth tranche 10,864 shares at $237.31 Non-derivative Common Shares sale on 2026-08-18 (weighted average price, range $237.10–$237.67)

Key Terms

weighted average price, open market or private transaction, non-derivative

3 terms

weighted average price financial

"The price reported in column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"Transaction code "S" denotes a sale in open market or private transaction."

non-derivative financial

"Each transaction is reported as a non-derivative Common Shares sale."

FAQ

What insider transactions did CAH report for Jessica L. Mayer on August 18, 2026?

Jessica L. Mayer sold 29,436 Common Shares of Cardinal Health (CAH) on August 18, 2026. The sales occurred in four separate open market or private transactions at weighted average prices between $234.07 and $237.67 per share.

At what prices were Jessica L. Mayer’s CAH shares sold on August 18, 2026?

The reported weighted average sale prices ranged from $234.64 to $237.31 per share. Footnotes clarify that underlying individual trades occurred within broader ranges of $234.07–$237.67, with full breakdowns available upon request to Cardinal Health or the SEC staff.

How many CAH shares did Jessica L. Mayer sell in each reported transaction?

Jessica L. Mayer sold 3,900, 10,246, 4,426, and 10,864 Common Shares in four separate transactions. Each transaction had its own weighted average sale price and corresponding intraday price range disclosed in the associated footnotes.

Were Jessica L. Mayer’s August 18, 2026 CAH share sales under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not affirmed, indicating these transactions are not reported as made under a Rule 10b5-1 trading plan. No separate footnote describes them as pre-arranged trading plan sales.

What type of security did Jessica L. Mayer sell in her CAH Form 4 filing?

All reported transactions involve Common Shares of Cardinal Health, Inc. The filing lists them as non-derivative securities, meaning they are the company’s ordinary shares rather than options, warrants, or other derivative instruments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/20/2026 - 07:29 AM Accepted by SEC EDGAR 08/20/2026 - 07:29 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mayer Jessica L

(Last) (First) (Middle)

7000 CARDINAL PLACE

(Street)

DUBLIN OHIO 43017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal/Compliance Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/18/2026		S		3,900	D	$234.64(1)	58,612	D
Common Shares	08/18/2026		S		10,246	D	$235.51(2)	48,366	D
Common Shares	08/18/2026		S		4,426	D	$236.38(3)	43,940	D
Common Shares	08/18/2026		S		10,864	D	$237.31(4)	33,076	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.07 to $235.05, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 2, 3, and 4 to this Form 4.

2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.08 to $236.07, inclusive.

3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.09 to $237.08, inclusive.

4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.10 to $237.67, inclusive.

Remarks:

	/s/ Amanda S. Pashi, Attorney-in-fact	08/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)